Shirakata Y et al. |
Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506. |
1995 |
Transplantation |
pmid:8545894
|
Aoyama H et al. |
Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. |
1995 |
Br. J. Dermatol. |
pmid:8547017
|
Gharpure VS et al. |
Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:8547871
|
Koch K et al. |
CP-123,369: a potent, orally active immunosuppressive agent. |
1995 |
Inflamm. Res. |
pmid:8548388
|
Lionetti P et al. |
Mucosal adaptation and destruction in response to lamina propria T cell activation in explants of human fetal intestine. |
1995 |
Adv. Exp. Med. Biol. |
pmid:8525974
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Clardy J |
The chemistry of signal transduction. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7529414
|
Braun W et al. |
Three-dimensional structure and actions of immunosuppressants and their immunophilins. |
1995 |
FASEB J. |
pmid:7529736
|
Kawai M et al. |
Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. |
1995 |
J. Immunol. |
pmid:7532665
|
Venkataraman L et al. |
FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. |
1995 |
J. Exp. Med. |
pmid:7532676
|
Zarnt T et al. |
Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond. |
1995 |
Biochem. J. |
pmid:7529995
|
Wang CR et al. |
T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. |
1995 |
J. Exp. Med. |
pmid:7532685
|
Wera S et al. |
Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression. |
1995 |
FEBS Lett. |
pmid:7530217
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Van Thiel DH et al. |
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7532912
|
Martinez OM et al. |
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533372
|
Fung JJ and Starzl TE |
FK506 in solid organ transplantation. |
1995 |
Ther Drug Monit |
pmid:8588226
|
Langrehr JM et al. |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. |
1995 |
Transplant. Proc. |
pmid:7533373
|
Jusko WJ |
Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring. |
1995 |
Ther Drug Monit |
pmid:8588227
|
Vargas V et al. |
Alpha-interferon for acute hepatitis C in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533374
|
McMaster P et al. |
Therapeutic drug monitoring of tacrolimus in clinical transplantation. |
1995 |
Ther Drug Monit |
pmid:8588228
|
Barkholt LM et al. |
New criteria for diagnosing cytomegalovirus hepatitis in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533375
|
Jusko WJ et al. |
Consensus document: therapeutic monitoring of tacrolimus (FK-506). |
1995 |
Ther Drug Monit |
pmid:8588229
|
Teraoka S et al. |
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. |
1995 |
Transplant. Proc. |
pmid:7533381
|
Lohse DL et al. |
Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1. |
1995 |
Structure |
pmid:8590008
|
Fay JW et al. |
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. |
1995 |
Transplant. Proc. |
pmid:7533383
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Zeevi A et al. |
Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533388
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Shapiro R et al. |
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533432
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Sakamoto K et al. |
Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. |
1995 |
Transplant. Proc. |
pmid:7533434
|
Ochiai T et al. |
Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533435
|
Scantlebury VP et al. |
Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. |
1995 |
Transplant. Proc. |
pmid:7533436
|
Hanafusa T et al. |
Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C. |
1995 |
Transplant. Proc. |
pmid:7533440
|
Bundick RV et al. |
The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity. |
1995 |
Clin. Exp. Immunol. |
pmid:7533681
|
Hirakata Y et al. |
Influence of various immunosuppressive agents on the occurrence of endogenous bacteraemia in mice. |
1995 |
J. Med. Microbiol. |
pmid:7533840
|
Iwasaki K et al. |
Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506. |
1995 |
Drug Metab. Dispos. |
pmid:7536652
|
Tumlin JA et al. |
Expression of calcineurin activity and alpha-subunit isoforms in specific segments of the rat nephron. |
1995 |
Am. J. Physiol. |
pmid:7485542
|
Furukawa F et al. |
FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. |
1995 |
Arch. Dermatol. Res. |
pmid:7487142
|
Winkler M and Christians U |
A risk-benefit assessment of tacrolimus in transplantation. |
1995 |
Drug Saf |
pmid:7545405
|
Miranker A and Karplus M |
An automated method for dynamic ligand design. |
1995 |
Proteins |
pmid:8749844
|
Marumo T et al. |
Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. |
1995 |
Hypertension |
pmid:7536714
|
Lapa e Silva JR et al. |
Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. |
1995 |
Eur. Respir. J. |
pmid:7489798
|
Nowaczyk M et al. |
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). |
1995 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:8744655
|
Schwaninger M et al. |
Involvement of the Ca(2+)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. |
1995 |
J. Biol. Chem. |
pmid:7536740
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Min Z and Jones NF |
Limb transplantation in rats: immunosuppression with FK-506. |
1995 |
J Hand Surg Am |
pmid:7536766
|
Petrides AS |
[Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?]. |
1995 |
Z Gastroenterol |
pmid:7571761
|
Lyons WE et al. |
Neuronal regeneration enhances the expression of the immunophilin FKBP-12. |
1995 |
J. Neurosci. |
pmid:7536825
|
Wortis HH et al. |
B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7536930
|
Bang H et al. |
Activation of Ca2+ signaling in neutrophils by the mast cell-released immunophilin FKBP12. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7536932
|
Yamamoto S et al. |
Cross-species transplantation of photoreceptors with tacrolimus hydrate (FK506) treatment. |
1995 |
Jpn. J. Ophthalmol. |
pmid:8926639
|
Lam E et al. |
A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. |
1995 |
J. Biol. Chem. |
pmid:7592869
|
Kanda T et al. |
Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7542339
|
Canzanello VJ et al. |
Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. |
1995 |
J. Am. Soc. Nephrol. |
pmid:7542491
|
Conde M et al. |
Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. |
1995 |
Immunology |
pmid:7538492
|
Garrett-Engele P et al. |
Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is essential in yeast mutants with cell integrity defects and in mutants that lack a functional vacuolar H(+)-ATPase. |
1995 |
Mol. Cell. Biol. |
pmid:7542741
|
Skeen MJ and Ziegler HK |
Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. |
1995 |
J. Immunol. |
pmid:7538532
|
Baughman G et al. |
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. |
1995 |
Mol. Cell. Biol. |
pmid:7542743
|
Columbo M et al. |
Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins. |
1995 |
J. Immunol. |
pmid:7538541
|
Pearlman DA and Connelly PR |
Determination of the differential effects of hydrogen bonding and water release on the binding of FK506 to native and Tyr82-->Phe82 FKBP-12 proteins using free energy simulations. |
1995 |
J. Mol. Biol. |
pmid:7538591
|
Warty V et al. |
Tacrolimus analysis: a comparison of different methods and matrices. |
1995 |
Ther Drug Monit |
pmid:7542809
|
Freeman DJ et al. |
Stability of FK 506 in whole blood samples. |
1995 |
Ther Drug Monit |
pmid:7542810
|
Dumont FJ et al. |
Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. |
1995 |
Cell. Immunol. |
pmid:7538911
|
Theopold U et al. |
FKBP39, a Drosophila member of a family of proteins that bind the immunosuppressive drug FK506. |
1995 |
Gene |
pmid:7538962
|
Zhao Y et al. |
Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. |
1995 |
J. Immunol. |
pmid:7539018
|
Lee MJ et al. |
Combined inhibition effects of tacrolimus and methylprednisolone on in vitro human lymphocyte proliferation. |
1995 |
Immunopharmacol Immunotoxicol |
pmid:7544367
|
Sauer P et al. |
In patients with orthotopic liver transplantation, serum markers of cholestasis are unreliable indicators of biliary secretion. |
1995 |
J. Hepatol. |
pmid:7544368
|
Chang HY et al. |
Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. |
1995 |
Nature |
pmid:7544441
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Llull R et al. |
Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. |
1995 |
Transplant. Proc. |
pmid:7544504
|
Horne SM and Young KD |
Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. |
1995 |
Arch. Microbiol. |
pmid:7540828
|
Teutsch M et al. |
Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. |
1995 |
Int. Immunol. |
pmid:7540861
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Mori A et al. |
IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. |
1995 |
Int. Immunol. |
pmid:7540862
|
Firdaous I et al. |
HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. |
1995 |
Clin. Chem. |
pmid:7544705
|
Tashiro H et al. |
Monitoring for engraftment following rat orthotopic liver transplantation by in vitro amplification of Y-chromosome gene using polymerase chain reaction. |
1995 |
Cell Transplant |
pmid:7540919
|
Ingels SC et al. |
Stability of FK506 (tacrolimus) in whole-blood specimens. |
1995 |
Clin. Chem. |
pmid:7544707
|
Hikita N et al. |
Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat. |
1995 |
Curr. Eye Res. |
pmid:7540967
|
Takizawa H et al. |
Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506. |
1995 |
Digestion |
pmid:7544748
|
Cardenas ME et al. |
Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. |
1995 |
EMBO J. |
pmid:7540976
|
Madsen KL et al. |
FK506 increases permeability in rat intestine by inhibiting mitochondrial function. |
1995 |
Gastroenterology |
pmid:7540994
|
Yang WM et al. |
Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. |
1995 |
J. Biol. Chem. |
pmid:7541038
|
Kawamura A and Su MS |
Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain. |
1995 |
J. Biol. Chem. |
pmid:7541044
|
Mueller AR et al. |
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506? |
1995 |
Clin Transplant |
pmid:7549057
|
Nagai H et al. |
Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. |
1995 |
Int. Arch. Allergy Immunol. |
pmid:7549508
|
Jung-Testas I et al. |
Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant. |
1995 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7583777
|
Kissinger CR et al. |
Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. |
1995 |
Nature |
pmid:8524402
|
Lauerma AI |
Immunomodulation of contact dermatitis. |
1995 |
Curr. Probl. Dermatol. |
pmid:7587333
|
Cardenas ME et al. |
Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. |
1995 |
Curr. Opin. Nephrol. Hypertens. |
pmid:8591053
|
Wera S et al. |
Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture. |
1995 |
Endocr. Res. |
pmid:7588431
|
Lake KD and Canafax DM |
Important interactions of drugs with immunosuppressive agents used in transplant recipients. |
1995 |
J. Antimicrob. Chemother. |
pmid:8601538
|
Cameron AM et al. |
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. |
1995 |
Cell |
pmid:8521476
|
Stoller G et al. |
A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. |
1995 |
EMBO J. |
pmid:7588623
|
Tamura K |
FK506: mechanism of immunosuppression and adverse-effects. |
1995 |
J Toxicol Sci |
pmid:8531246
|
Farcasanu IC et al. |
Protein phosphatase 2B of Saccharomyces cerevisiae is required for tolerance to manganese, in blocking the entry of ions into the cells. |
1995 |
Eur. J. Biochem. |
pmid:7588708
|
Mugiya S et al. |
Renal blood flow, fibrinolysis, and platelet aggregation following tacrolimus (FK 506) treatment in rats. |
1995 |
Thromb. Res. |
pmid:8533130
|
Kaplan A et al. |
The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. |
1995 |
J. Dermatol. Sci. |
pmid:8534611
|
Zhu X et al. |
Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells. |
1995 |
Ann. Hematol. |
pmid:8534762
|